ET-1-associated vasomotion and vasospasm in lymphatic vessels of the guinea-pig mesentery

British Journal of Pharmacology

Volumn 140, Issue 8, 2003, Pages 1399-1413

  Zhao, Jun ^a   Van Helden, Dirk F ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Ca 2+ influx; Ca 2+ release; Endothelin 1; Lymphatics; Vasomotion; Vasospasm

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CAFFEINE; CALCIUM; CALCIUM CHANNEL L TYPE; CESIUM; CORONARY VASODILATING AGENT; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPARIN; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; RYANODINE; SKF 96165; THAPSIGARGIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CHELATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTRIC POTENTIAL; ENDOTHELIUM; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; GUINEA PIG; IN VITRO STUDY; LYMPH VESSEL; LYMPHATIC SYSTEM; MESENTERY; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; SMOOTH MUSCLE; VASOSPASM;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; ENDOTHELIN-1; ENDOTHELIUM, LYMPHATIC; GUINEA PIGS; IMIDAZOLES; INOSITOL PHOSPHATES; LYMPHATIC VESSELS; MESENTERY; MUSCLE, SMOOTH; RECEPTOR, ENDOTHELIN A; SIGNAL TRANSDUCTION;

EID: 0347949527     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705573     Document Type: Article

References (70)

1. ASCHER-LANDSBERG, J., SAUNDERS, T., ELOVITZ, M. & PHILLIPPE, M. (1999). The effects of 2-aminoethoxydiphenyl borate, a novel inositol 1,4,5-trisphosphate receptor modulator on myometrial contractions. Biochem. Biophys. Res. Commun., 264, 979-982.
2. BEAVO, J.A. & REIFSNYDER, D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 150-155.
3. BERRIDGE, M.J. (1993). Inositol trisphosphate and calcium signalling. Nature, 361, 315-325.
4. 3-and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature, 351, 751-754.
5. BLEASDALE, J.E., THAKUR, N.R., GREMBAN, R.S., BUNDY, G.L., FITZPATRICK, F.A., SMITH, R.J. & BUNTING, S. (1990). Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther., 255, 756-768.
6. 2 synthesis in a murine macrophage cell line. J. Pharmacol. Exp. Ther., 244, 765-773.
7. CHEN, C. & WAGONER, P.K. (1991). Endothelin induces a nonselective cation current in vascular smooth muscle cells. Circ. Res., 69, 447-454.
8. CHERNAYA, G., VAZQUEZ, M. & REEVES, J.P. (1996). Sodium-calcium exchange and store-dependent calcium influx in transfected Chinese hamster ovary cells expressing the bovine cardiac sodium-calcium exchanger. Acceleration of exchange activity in thapsigargin-treated cells. J. Biol. Chem., 271, 5378-5385.
9. CHIAVAROLI, C., BIRD, G. & PUTNEY JR, J.W. (1994). Delayed 'all-or-none' activation of inositol 1,4,5-trisphosphate-dependent calcium signaling in single rat hepatocytes. J. Biol. Chem., 269, 25570-25575.
10. COESSENS, B.C. (1994). Endothelin: an endothelium-derived vasoactive peptide. J. Reconstr. Microsurg., 10, 405-410.
11. CONSIGNY, P.M. (1990). Endothelin-1 increases arterial sensitivity to 5-hydroxytryptamine. Eur. J. Pharmacol., 186, 239-245.
12. 2+ release in agonist-induced contractions in guinea pig trachea. Am. J. Physiol., 266, L620-L627.
13. DARBY, P.J., KWAN, C.Y. & DANIEL, E.E. (1993). Use of calcium pump inhibitors in the study of calcium regulation in smooth muscle. Biol. Signals, 2, 293-304.
14. A antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEBS Lett., 302, 243-246.
15. EHRLICH, B.E. & WATRAS, J. (1988). Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature, 336, 583-586.
16. FIELDS, T.A. & CASEY, P.J. (1997). Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J., 321, 561-571.
17. FLOREY, H.W. (1927). Observations on the contractility of lacteals. Part 1. J. Physiol. (Lond.), 62, 1-18.
18. FURUYA, K., FURUYA, S. & YAMAGISHI, S. (1994). Intracellular calcium responses and shape conversions induced by endothelin in cultured subepithelial fibroblasts of rat duodenal villi. Pflugers Arch., 428, 97-104.
19. GHOSH, T.K., EIS, P.S., MULLANEY, J.M., EBERT, C.L. & GILL, D.L. (1988). Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J. Biol. Chem., 263, 11075-11079.
20. 2+ in cultured arterial smooth muscle cells using Fura-2 and digital imaging microscopy. Cell Calcium, 11, 221-231.
21. 2+ channel in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 86, 3915-3918.
22. 2+ channels in liver cells, and acts through a mechanism which does not involve inositol trisphosphate receptors. Biochem. J., 354, 285-290.
23. HADDOCK, R.E., HIRST, G.D. & HILL, C.E. (2002). Voltage independence of vasomotion in isolated irideal arterioles of the rat. J. Physiol. (Lond.), 540, 219-229.
24. 2+ mobilization in human gastric mucus secreting cells. Biochim. Biophys. Acta, 1356, 198-206.
25. HASHITANI, H., VAN HELDEN, D.F. & SUZUKI, H. (1996). Properties of spontaneous depolarizations in circular smooth muscle cells of rabbit urethra. Br. J. Pharmacol., 118, 1627-1632.
26. HAYNES, W.G. & WEBB, D.J. (1993). The endothelin family of peptides: local hormones with diverse roles in health and disease? Clin. Sci. (Lond.), 84, 485-500.
27. 2+ level. Naunyn-Schmiedeberg's Arch. Pharmacol., 341, 80-87.
28. A receptor. J. Cardiovasc. Pharmacol., 20, S11-S14.
29. ISHIKAWA, K., IHARA, M., NOGUCHI, K., MASE, T., MINO, N., SAEKI, T., FUKURODA, T., FUKAMI, T., OZAKI, S., NAGASE, T., NISHIKIBE, M. & YANO, M. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A., 91, 4892-4896.
30. JOHNSON, P.C. (1980). The myogenic response. In: Handbook of Physiology: The Cardiovascular System, ed. Geiger, S.R., Bohr, D.F., Somlyo, A.P. & Sparks, H.V. pp. 400-442. Bethesda, MD: American Physiological Society.
31. JOHNSTON, M.G. & ELIAS, R. (1987). The regulation of lymphatic pumping. Lymphology, 20, 215-218.
32. 2 during repeated downregulation of epsilon-protein kinase C. J. Cardiovasc. Pharmacol., 35, 491-501.
33. KOBAYASHI, S., SOMLYO, A.V. & SOMLYO, A.P. (1988). Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle. Biochem. Biophys. Res. Commun., 153, 625-631.
34. KURIHARA, H., YAMAOKI, K., NAGAI, R., YOSHIZUMI, M., TAKAKU, F., SATOH, H., INUI, J. & YAZAKI, Y. (1989). Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life Sci., 44, 1937-1943.
35. KWAN, A.L., LIN, C.L., CHANG, C.Z., WINARDI, D., YEN, C.P., WU, S.C., LEE, K.S., KASSELL, N.F., HOWNG, S.L., SAVAGE, P. & JENG, A.Y. (2002). Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits. Clin. Sci. (Lond.), 103, 414S-417S.
36. MARSDEN, P.A., DANTHULURI, N.R., BRENNER, B.M., BALLERMANN, B.J. & BROCK, T.A. (1989). Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. Biochem. Biophys. Res. Commun., 158, 86-93.
37. 2+ release. J. Biochem. (Tokyo), 122, 498-505.
38. MCHALE, N.G. (1990). Lymphatic innervation. Blood Vessels. 27, 127-136.
39. MERRITT, J.E., ARMSTRONG, W.P., BENHAM, C.D., HALLAM, T.J., JACOB, R., JAXA-CHAMIEC, A., LEIGH, B.K., MCCARTHY, S.A., MOORES, K.E. & RINK, T.J. (1990). SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J., 271, 515-522.
40. MISLIN, H. (1983). The Lymphangion. In: Lymphangiology. ed. Foldi, M. & Casley-Smith, J.R. pp. 165-175. New York: F.K. Schattauer Verlag.
41. NEYLON, C.B. (1999). Vascular biology of endothelin signal transduction. Clin. Exp. Pharmacol. Physiol., 26, 149-153.
42. 2+ sensitivity in alpha-toxin-permeabilized rabbit mesenteric artery. Circ. Res., 71, 951-959.
43. OHHASHI, T., AZUMA, T. & SAKAGUCHI, M. (1978). Transmembrane potentials in bovine lymphatic smooth muscle. Proc. Soc. Exp. Biol. Med., 159, 350-352.
44. ORTEGA MATEO, A. & DE ARTINANO, A.A. (1997). Highlights on endothelins: a review. Pharmacol. Res., 36, 339-351.
45. OTA, M. & OKU, H. (1997). Nicardipine modification of endothelin-1 effects on visual evoked potential. Jpn. J. Ophthalmol., 41, 38-42.
46. PANG, C.Y., XU, H., HUANG, N., FORREST, C.R., PERREAULT, T.M. & NELIGAN, P.C. (2001). Amplification effect and mechanism of action of ET-1 in U-46619-induced vasoconstriction in pig skin. Am. J. Physiol. Regul. Integr. Comp. Physiol., 280, R713-R720.
47. 2. Br. J. Pharmacol., 121, 1589-1596.
48. REEDER, L.B. & FERGUSON, M.K. (1996). Endothelin-1 synthesis and receptor-mediated activity in porcine lymph vessels. J. Surg. Res., 63, 215-219.
49. SAKAI, H., IKOMI, F. & OHHASHI, T. (1999). Effects of endothelin on spontaneous contractions in lymph vessels. Am. J. Physiol., 277, H459-H466.
50. A antagonist, on endothelin-mediated vasomotion in rat coronary vascular beds. J. Cardiovasc. Pharmacol., 26, S400-S403.
51. i oscillations? Challenging the capacitative model. Cell Calcium, 25, 237-246.
52. SIROUS, Z.N., FLEMING, J.B. & KHALIL, R.A. (2001). Endothelin-1 enhances eicosanoids-induced coronary smooth muscle contraction by activating specific protein kinase C isoforms. Hypertension, 37, 497-504.
53. SOKOLOVSKY, M., AMBAR, I. & GALRON, R. (1992). A novel subtype of endothelin receptors. J. Biol. Chem., 267, 20551-20554.
54. TAKEMURA, H., THASTRUP, O. & PUTNEY JR, J.W. (1990). Calcium efflux across the plasma membrane of rat parotid acinar cells is unaffected by receptor activation or by the microsomal calcium ATPase inhibitor, thapsigargin. Cell Calcium, 11, 11-17.
55. THOMPSON, A.K., MOSTAFAPOUR, S.P., DENLINGER, L.C., BLEASDALE, J.E. & FISHER, S.K. (1991). The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J. Biol. Chem., 266, 23856-23862.
56. TORIBATAKE, Y., TOMITA, K., KAWAHARA, N., BABA, H., OHNARI, H. & TANAKA, S. (1997). Regulation of vasomotion of arterioles and capillaries in the cat spinal cord: role of alpha actin and endothelin-1. Spinal Cord, 35, 26-32.
57. TSUGENO, M., HUANG, S.M., PANG, Y.W., CHOWDHURY, J.U. & TOMITA, T. (1995). Effects of phosphodiesterase inhibitors on spontaneous electrical activity (slow waves) in the guinea-pig gastric muscle. J. Physiol. (Lond.), 485, 493-502.
58. VAN HELDEN, D.F. (1993). Pacemaker potentials in lymphatic smooth muscle of the guinea-pig mesentery. J. Physiol. (Lond.), 471, 465-479.
59. VAN HELDEN, D.F., IMTIAZ, M.S., NURGALIYEVA, K., VON DER WEID, P. & DOSEN, P.J. (2000). Role of calcium stores and membrane voltage in the generation of slow wave action potentials in guinea-pig gastric pylorus. J. Physiol. (Lond.), 524, 245-265.
60. VAN RENTERGHEM, C., VIGNE, P., BARHANIN, J., SCHMID-ALLIANA, A., FRELIN, C. & LAZDUNSKI, M. (1988). Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem. Biophys. Res. Commun., 157, 977-985.
61. VOLPE, M. & COSENTINO, F. (2000). Abnormalities of endothelial function in the pathogenesis of stroke: the importance of endothelin. J. Cardiovasc. Pharmacol., 35, S45-S48.
62. VON DER WEID, P.Y., CROWE, M.J. & VAN HELDEN, D.F. (1996). Endothelium-dependent modulation of pacemaking in lymphatic vessels of the guinea-pig mesentery. J. Physiol. (Lond.), 493, 563-575.
63. WANEBO, J.E., ARTHUR, A.S., LOUIS, H.G., WEST, K., KASSELL, N.F., LEE, K.S. & HELM, G.A. (1998). Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Neurosurgery, 43, 1409-1417.
64. WICKMAN, G., NESSIM, M.A., COOK, D.A. & VOLLRATH, B. (2001). The polycationic aminoglycosides modulate the vasoconstrictive effects of endothelin: relevance to cerebral vasospasm. Br. J. Pharmacol. 133, 5-12.
65. WILLETTE, R.N., ZHANG, H., MITCHELL, M.P., SAUERMELCH, C.F., OHLSTEIN, E.H. & SULPIZIO, A.C. (1994). Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke, 25, 2450-2455.
66. YANAGISAWA, M., INOUE, A., ISHIKAWA, T., KASUYA, Y., KIMURA, S., KUMAGAYE, S., NAKAJIMA, K., WATANABE, T.X., SAKAKIBARA, S., GOTO, K. & MASAKI, T. (1988). Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc. Natl. Acad. Sci. U.S.A., 85, 6964-6967.
67. ZHAO, J. & VAN HELDEN, D.F. (1997). Role of endothelin-1 in modulation of lymphatic pacemaking. Proc. Austral. Physiol. Pharmacol. Soc., 28, 80.
68. 2Y receptors. Br. J. Pharmacol., 137, 477-487.
69. 2+ in subarachnoid hemorrhage-induced spasm of the rabbit basilar artery. Stroke, 27, 1896-1902.
70. ZUCCARELLO, M., SOATTIN, G.B., LEWIS, A.I., BREU, V., HALLAK, H. & RAPOPORT, R.M. (1996b). Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J. Neurosurg., 84, 503-507.